Functional imaging may be useful for both the early diagnosis as well as preclinical detection of neurodegenerative disease. Additionally, while structural imaging has traditionally been regarded as a tool to exclude alternate diagnoses, recent advances in magnetic resonance show promise for greater diagnostic specificity. The role of MR and radionuclide imaging in early diagnosis and preclinical detection of dementia and parkinsonism are reviewed here. © 2012 Stoessl; licensee BioMed Central Ltd.
CITATION STYLE
Stoessl, A. J. (2012, January 13). Neuroimaging in the early diagnosis of neurodegenerative disease. Translational Neurodegeneration. https://doi.org/10.1186/2047-9158-1-5
Mendeley helps you to discover research relevant for your work.